DAIICHI SANKYO COMPANY, LIMITED

DAIICHI SANKYO COMPANY, LIMITED

ASCO Highlights 2023

June 6, 2023

PLAY LIST

from the beginning

1.Introduction
2.R&D strategy
3.Highlights from ASCO & ESMO Breast
4.Closing
Q&A
  • Q&A 1
  • Q&A 2
  • Q&A 3
  • Q&A 4
  • Q&A 5
  • Q&A 6
Sunao Manabe, Executive Chairperson and CEO
Ken Takeshita, Global R&D Head
Mark Rutstein, Head of Global Oncology Clinical Development

Download

  • Presentation Material(PDF 5 MB)
  • Questionnaire Please answer the questionnair
  • Forward-Looking Statements
    System Requirements
GreenPower
link corporate communications